血管介入治疗应用于肝癌综合治疗的临床价值  

Clinical Value of Vascular Interventional Therapy in Treatment of Liver Cancer

作　　者：余杰[1] 韩梅[1] 欧阳华忠[1] YU Jie;HAN Mei;OUYANG Hua-zhong(No.7 Division Hospital of Xinjiang Production and Construction Corps,Kuitun,Xinjiang)

机构地区：[1]新疆生产建设兵团第七师医院,新疆奎屯

出　　处：《世界最新医学信息文摘》2019年第105期29-30,共2页World Latest Medicine Information Electronic Version

摘　　要：目的探讨肝癌综合治疗中运用血管介入治疗的临床效果。方法选择2015年1月至2016年1月我院收治的78例肝癌患者为研究对象,随机分为两组,其中对照组行非介入治疗,而观察组则运用血管介入治疗,对比分析两组效果。结果治疗前,两组的肌酐、尿素氮以及甲胎蛋白水平比较无差异(P>.05);治疗后,观察组的尿素氮、甲胎蛋白以及肌酐水平均优于对照组(P<0.05);与对照组相比,观察组的临床缓解率高,组间比较差异明显(P<0.05);同时,两组1年、2年以及3年的生存率对比有统计学意义(P<0.05)。结论临床上给予肝癌患者血管介入治疗可以提高生存率。Objective To explore clinical effect of interventional therapy on comprehensive treatment of liver cancer.Methods Choose 78 cases liver cancer patients admitted to our hospital from January 2015 to January 2016 as research objects,divide them into two groups randomly.Control group was treated with noninvasive therapy,while observation group with vascular interventional therapy.Compare and analze effect of two groups.Results Before treatment,levels of creatinine,urea nitrogen and alpha fetoprotein showed no difference between two groups(P>0.05);after treatment,urea nitrogen,alpha fetoprotein and creatinine levels in observation group were better than control group(P<0.05);clinical remission rate of observation group was higher than control group,difference was significant between groups(P<0.05);at the same time,survival rates comparison of one,two and three years in two groups showed statistical significance(P<0.05).Conclusion Interventional therapy can improve survival rate of liver cancer patients in clinical practice.

关 键 词：肝癌 血管介入治疗 生存率 

分 类 号：R735.7[医药卫生—肿瘤]